Despite being primarily secreted in liver, in our study IGF1 demonstrated an adrenal gland and muscle specific regulatory circuit with CVD and T2D genes, suggesting that it may confer risk to these diseases through the adrenal endocrine function and muscle insulin sensitivity. The gene discussed is INS; the disease is type 2 diabetes mellitus.